Cybin Inc. Common Stock AGM 2026

The Annual General and Special Meeting of Shareholders of Cybin Inc, doing business as Helus Pharma, is about to commence.

Hello, and welcome to Cybin Inc, doing business as Helus Pharma's Annual General and Special Meeting of Shareholders. The meeting will now come to order. My name is Eric So, and I am a director of the corporation. I will act as chair of the meeting. I have appointed Sherri Altshuler to act as secretary of the meeting. Heather Conran of Odyssey Trust Company will act as scrutineer for the meeting. I would also like to introduce the following officers and directors of the corporation in attendance at the meeting. Michael Halstead, chief executive officer, Greg Cavers, chief financial officer, Paul Glavin, director. The meeting is being hosted on Odyssey's virtual shareholder meeting platform. This allows registered shareholders to vote and submit questions and comments to the moderator to be read and addressed during the meeting.

If you have a question or comment, please submit it through the system, and we will answer it at the appropriate time. Proof of the mailing of the shareholders of record as of the close of business on Friday, August 14, 2026, of the notice of Annual General and Special Meeting of Shareholders, together with the management information circular, the form of proxy, and the financial statement request card have been filed, and I direct the proof of mailing be kept by the secretary with the records of this meeting. The notice sets out the various matters to be dealt with at the meeting today. I would suggest that all shareholders have a copy of the notice of management information circular in front of them, as it will be easier to follow the meeting. I am advised by the scrutineer that there is quorum present.

The scrutineer's report will be available from the secretary following the meeting. I declare that the meeting is rarely called and properly constituted and it is in order for us to proceed with the transaction of business. Before commencing the business of the meeting, I would like to comment on the voting procedure. Each holder of common share is entitled to one vote for each share held by the holder in respect of each matter to be dealt with at the meeting. We will conduct each vote by way of vote cast on Odyssey's virtual platform and those submitted by proxy. I understand that the scrutineer has tabulated all of the votes received prior to the voting cutoff. If you have previously voted, you do not need to vote again when prompted. By voting again, you will revoke any previous vote made prior to the voting cutoff.

We'll now open the voting for the resolutions. Particulars of the vote cast on each matter may be obtained from the secretary after the meeting. The first item of business is the laying before the meeting of the financial statements of the corporation for the year ended March 31, 2026, and the report of the auditor thereon. Copies of the financial statements and the report of the auditor thereon may be obtained at sedarplus.ca or on the corporation's website on the Investors tab. The next item of business is the appointment of the auditor. I would ask for a motion to appoint Zeifmans LLP as auditor of the corporation and authorize the directors of the corporation to fix the remuneration to be paid to the auditor.

My name is Greg Cavers, and I move the motion.

Is there a seconder? Paul Glavin, I second the motion.

Is there any discussion or questions submitted from any registered shareholder or proxy holder? For those who have not voted on the resolution, please do so now. Voting on the resolution will close after all resolutions have been put before the meeting. The next item of business is a special resolution setting the number of directors of the corporation at eight. An affirmative vote of not less than two-thirds of the votes cast at the meeting is sufficient to pass such resolution. May I have a motion to pass as a special resolution the setting the number of directors of the corporation at eight?

My name is Greg Cavers, and I move the motion.

Is there a seconder? Paul Glavin, I second the motion.

Is there any discussion or questions submitted from any registered shareholder or proxy holder? For those who have not voted on the resolution, please do so now. Voting on the resolution will close after all resolutions have been put before the meeting. The next item of business is a special resolution approving a change of the corporation's name from Cybin Inc. to Helus Pharma Inc. or such other name as may be approved by the directors of the corporation and acceptable to the applicable regulatory authorities. An affirmative vote of not less than two-thirds of the vote cast at the meeting is sufficient to pass such resolution. May I have a motion to pass a special resolution changing the name of the corporation from Cybin Inc. to Helus Pharma Inc.?

My name is Greg Cavers, and I move the motion.

Is there a seconder? Paul Glavin, I second the motion.

Is there any discussion or questions submitted from any registered shareholder or proxy holder? For those who have not voted on the resolution, please do so now. Voting on the resolution will close after all resolutions have been put before the meeting. We will now proceed to the election of directors. Only persons who have been nominated in accordance with the procedure set out in bylaw one of the corporation shall be eligible for election as directors. The management information circular contains the names of management's nominees to the board of directors. I am advised that there are no other nominations for election to the board were duly received. Therefore, pursuant to bylaw one, nominations from the floor of the meeting other than management's nominees will not be accepted. I now declare the meeting open for nomination of directors.